Redefining Skin Biopsy

An innovative elliptical punch biopsy device that delivers superior cosmetic outcomes without compromising clinical efficiency

Learn More See It in Action Clinical Feedback Partnership Opportunities

The Problem

⚠️

Suboptimal Cosmesis

Conventional circular punch biopsies often leave puckered, widened, and cosmetically unfavorable scars

⏱️

Time Constraints

Traditional fusiform excisions yield better scars but are too time-consuming for high-volume clinical settings

📊

Limited Options

Clinicians must choose between speed and cosmetic outcome, with no optimal middle ground

Our Solution

Elliptical Punch Biopsy Device

The Revedeon elliptical punch biopsy device bridges the gap between speed and cosmetic outcome. Our patented technology produces an elliptical, fusiform-like defect without the extra time and complexity of traditional elliptical excisions.

✓

Superior Cosmesis

Creates linear wounds that align with relaxed skin tension lines

✓

Maintained Efficiency

Fast procedure time comparable to circular punches

✓

Adjustable Depth

Simple depth control without complex mechanisms

✓

Easy Adoption

Intuitive design fits seamlessly into existing workflows

✓

Multiple Sizes

Designed to accommodate a range of lesion sizes (4–12 mm)

Device in Action

Watch the elliptical punch biopsy device compared to traditional circular punches

Technology & Innovation

Patented Design

The device incorporates a fusiform blade that creates an elliptical wound while maintaining the simplicity and speed of a traditional punch biopsy. This patented approach addresses a fundamental limitation in current dermatologic practice.

Clinical Advantages

By producing wounds that better align with relaxed skin tension lines, the device reduces puckering and may improve healing outcomes. The result is a more cosmetically favorable linear scar that may benefit both patients and practitioners.

Workflow Integration

Designed for seamless integration into high-volume clinical settings, the device maintains procedural efficiency while delivering superior cosmetic results. The adjustable depth control adds precision without adding complexity.

Comparative Advantages

vs. Circular Punches

  • Better cosmetic outcomes
  • Reduced scarring and puckering
  • Similar procedural speed
  • Comparable cost profile

vs. Fusiform Excisions

  • Significantly faster procedure
  • Simpler technique
  • Similar cosmetic results
  • Better workflow efficiency

vs. Complex Systems

  • Lower manufacturing cost
  • Easier adoption curve
  • No complex mechanisms
  • Proven design principles

Market Opportunity

Addressing a Clear Clinical Need

The elliptical skin biopsy device was developed through firsthand clinical insights in fellowship-trained Mohs micrographic surgery, translating a persistent procedural challenge into an innovative solution.

Target Markets

Dermatology Practices

High-volume dermatologists performing routine diagnostic biopsies and skin cancer evaluations

Plastic Surgery

Cosmetic and reconstructive surgeons prioritizing aesthetic outcomes in facial and visible areas

Primary Care

Family physicians and internal medicine practitioners performing outpatient skin procedures

Advanced Practice

Physician assistants and nurse practitioners conducting skin biopsies in clinic settings

Market Drivers

01

Growing Skin Cancer Incidence

Rising global rates of skin cancer drive increased diagnostic biopsy volumes across all practice settings

02

Cosmetic Expectations

Patient demand for optimal cosmetic outcomes continues to grow, particularly in aesthetic-conscious markets

03

Reimbursement Alignment

Compatible with existing reimbursement frameworks for small excisions, facilitating adoption

04

Practice Differentiation

Enables clinicians to differentiate their practice through improved patient outcomes and satisfaction

Development Roadmap

Revedeon seeks a manufacturing partner to advance this technology through commercialization, handling prototype development, 510(k) clearance, manufacturing, and distribution under a royalty-based arrangement.

1

Design for Manufacturing

Refine design specifications and optimize for large-scale production

2

Preclinical Testing

Complete usability and user-experience evaluations with target clinicians

3

510(k) Clearance

Navigate FDA premarket notification and prepare regulatory submissions

4

Clinical Adoption

Establish early clinical use and collect post-market data on outcomes and satisfaction

About the Founder

Alex Reid, MD

Alex Reid, MD

Fellowship-Trained Mohs Micrographic Surgeon

Dr. Reid brings extensive clinical experience in cutaneous oncology and procedural dermatology to the development of innovative surgical tools designed to improve patient outcomes.

Education & Training

  • Medical School: University of Michigan Medical School
  • Dermatology Residency: University of Iowa
  • Mohs Fellowship: Geisinger Medical Center

Vision

Through years of high-volume clinical practice performing skin cancer surgeries and diagnostic biopsies, Dr. Reid identified a persistent gap in available tools: conventional circular punch biopsies routinely produce suboptimal cosmetic outcomes, yet time constraints make traditional fusiform excisions impractical for most settings.

This device represents a direct translation of clinical insight into a practical solution — delivering improved cosmetic outcomes without compromising the efficiency that busy practices require.

alexreidmd.com alexreidmdblog.com ergosherpa.com — Ergonomics App for Proceduralists

Patent Information

US Patent No. 11,805,997 B2

Title: Skin Biopsy Device

Assignee: Revedeon, LLC

Date of Patent: November 7, 2023

The patent covers devices and methods for performing skin biopsies with consistent depth and shape. The device provides for reducing or eliminating operator error and inter-operator variability by generating the same forces across multiple uses, while also incorporating a fusiform blade to eliminate puckering of wound closures.

Frequently Asked Questions

What is the Revedeon elliptical punch biopsy device?

A patented surgical instrument (US Patent No. 11,805,997 B2) that produces fusiform-like wound geometry at the speed of a conventional circular punch biopsy — eliminating dog-ear formation and improving cosmetic outcomes without additional procedural time.

Is it FDA cleared or commercially available?

No. The device is a patented concept and is not yet FDA cleared or commercially available. Revedeon is seeking a manufacturing partner to advance the device through 510(k) premarket clearance and commercialization.

How does it differ from a standard circular punch biopsy?

Conventional circular punches create round wounds that misalign with relaxed skin tension lines, producing puckered, cosmetically unfavorable scars. The Revedeon device uses a fusiform blade to create an elliptical wound aligned with skin tension lines — yielding results comparable to a fusiform excision at circular-punch speed.

What sizes will be available?

The device is designed in a range of sizes from 4 to 12 mm, accommodating the variety of lesion sizes encountered in routine dermatologic and procedural practice.

What type of manufacturing partner is Revedeon seeking?

Revedeon is seeking an established medical device manufacturer to take on prototype development, 510(k) FDA clearance, manufacturing, and distribution under a royalty-based arrangement. Dr. Reid provides clinical expertise and technical collaboration throughout the process.

Partner With Revedeon

The device is patented and ready for the right industry partner to advance the elliptical punch biopsy through commercialization. We welcome inquiries from manufacturers, distributors, and strategic collaborators.

Clinical Feedback

Practicing dermatologists, Mohs surgeons, and proceduralists — share your experience with current circular punch limitations and help inform the device design.

Share Feedback

Partnership Inquiry

Medical device manufacturers and industry partners interested in advancing the elliptical punch biopsy from patented concept to commercial product.

Submit Inquiry